文献速递肿瘤 PET/CT

18F-FDG/18F-胆碱双示踪剂PET表现能否作为肝细胞癌肿瘤分化的替代指标:一项三级中心专项研究

Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study.
PubMed 文献 · Clin Nucl Med · 2023-01-14

该回顾性研究纳入49个经组织学证实的肝细胞癌病灶(46例接受手术或肝移植的患者),评估基线18F-FDG与18F-胆碱PET/CT作为肿瘤分化替代指标的相关性。结果显示除18F-FDG肿瘤/本底比值在III级高于I级和II级外,其余PET指标在各分化级别间无统计学差异;作者认为双示踪剂PET表现并非肝细胞癌肿瘤分化的可靠替代指标。

要点

  • 49个肝细胞癌病灶中,仅18F-FDG肿瘤/本底比值在III级高于I级(校正P=0.02)和II级(校正P=0.01)。
  • 其余PET视觉分析与半定量指标在各分化级别间均无统计学差异。
  • 作者认为18F-FDG/18F-胆碱双示踪剂PET表现不是肝细胞癌肿瘤分化的可靠替代指标。

核心结论

  • 与常见观念相反,18F-FDG/18F-胆碱双示踪剂PET表现并非肝细胞癌肿瘤分化的可靠替代指标。
  • 作者认为未来需要多示踪剂PET研究以细化对其深层生物学意义的认识。

研究设计与样本

  • 回顾性研究,共纳入49个经组织学证实的肝细胞癌病灶(46例接受手术或肝移植的患者)。
  • 所有病灶均有可用的基线18F-FDG与18F-胆碱PET/CT、专用肝脏增强CT及组织学关键特征。
  • 按世界卫生组织分类将肿瘤分为高分化(I级)、中分化(II级)和低分化(III级)进行比较。
  • PET分析采用双盲视觉分析和8项常用半定量指标,统计方法为非参数Kruskal-Wallis方差分析,显著性后行配对事后检验并校正族错误率。

主要发现

  • 各分化级别间患者或病灶特征均无统计学差异(P>0.05),仅I级与II级间大血管侵犯有差异(校正P=0.03)。
  • 各分化级别间PET指标均无统计学差异,仅18F-FDG肿瘤/本底比值III级高于I级(校正P=0.02)和II级(校正P=0.01)。
  • 14个病灶(28.5%)视觉判断为区域摄取不均质,但相关半定量PET指标均无统计学判别力(P>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In hepatocellular carcinoma (HCC) setting, 18 F-FDG and 18 F-choline PET/CT radiotracers are classically considered surrogates of the degree of differentiation, a strong predictor of disease recurrence after curative treatment. Because the corresponding level of evidence has never been assessed as primary end point, the aim of this retrospective study was to specifically assess the relevance of 18 F-FDG combined to 18 F-choline PET imaging as a surrogate of tumor differentiation in HCC. PATIENTS AND METHODS: A total of 49 histologically proven HCCs (46 patients treated by surgery or liver transplantation) with available baseline 18 F-FDG and 18 F-choline PET/CT, dedicated liver contrast-enhanced CT scan, and histological key features were retrospectively reviewed. Hepatocellular carcinoma tumors with well, moderately, and poorly differentiation (grades I, II, and III of the World Health Organization classification) were compared on their PET findings (double-blinded visual analysis and 8 usual semiquantitative metrics) by using nonparametric Kruskal-Wallis analyses of variance. In the case of statistical significance, pairwise post hoc tests with family-wise error rate adjustment were performed. RESULTS: No statistical difference between the grades was observed for any of the patients' or lesions' characteristics ( P > 0.05), except for the macrovascular invasion between the grades I and II (adjusted P = 0.03). None of the PET findings showed statistical difference between the grades, except the tumor-to-background ratio of 18 F-FDG, higher for the grade III compared with grades I (adjusted P = 0.02) and II (adjusted P = 0.01). For less than one third of cases (14 lesions; 28.5%), the regional uptake was judged visually heterogeneous, but none of the related semiquantitative PET metrics were statistically discriminant ( P > 0.05). CONCLUSIONS: Contrary to a common belief, 18 F-FDG/ 18 F-choline dual-tracer PET behavior is not a relevant surrogate of tumor differentiation in HCC. Future multitracer PET studies are mandatory to refine our knowledges of their deep biological meaning in this field.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sivapathasundaram A, Golse N, Pascale A, et al. Is 18 F-FDG/ 18 F-Choline Dual-Tracer PET Behavior a Surrogate of Tumor Differentiation in Hepatocellular Carcinoma : A Tertiary Center Dedicated Study. Clin Nucl Med. 2023. PMID: 36728133. doi:10.1097/RLU.0000000000004574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。